Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current MRNA market cap is 16.7B. The company's latest EPS is USD -12.2500 and P/E is -3.52.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 344M | 1.83B | 2.81B | 167M | 241M |
| Operating Income | -1.87B | -2.01B | 6M | -1.27B | -1.36B |
| Net Income | -1.38B | -3.63B | 217M | -1.18B | -1.28B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 60.21M | 803.4M | 18.47B | 19.26B | 6.85B |
| Operating Income | -545.72M | -763.14M | 13.3B | 9.42B | -4.24B |
| Net Income | -514.02M | -747.1M | 12.2B | 8.36B | -4.71B |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 21.88B | 19.45B | 18.43B | 16.73B | 15.68B |
| Total Liabilities | 4.94B | 6B | 4.57B | 3.91B | 3.97B |
| Total Equity | 16.95B | 13.46B | 13.85B | 12.82B | 11.71B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.59B | 7.34B | 24.67B | 25.86B | 18.43B |
| Total Liabilities | 414.61M | 4.78B | 10.52B | 6.74B | 4.57B |
| Total Equity | 1.17B | 2.56B | 14.15B | 19.12B | 13.85B |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.14B | -3.74B | -3.12B | -989M | -2.26B |
| Investing | 3.96B | 4.74B | 4.21B | 118M | 1.77B |
| Financing | -1.21B | -1.27B | -1.38B | 14M | 48M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -458.97M | 2.03B | 13.62B | 4.98B | -3.12B |
| Investing | -14.95M | -1.67B | -8.52B | -5.18B | 4.21B |
| Financing | 51.12M | 2.03B | -873M | -3.45B | -1.38B |
| Market Cap | 16.7B |
| Price to Earnings Ratio | -3.52 |
| Price to Sales Ratio | 2.42 |
| Price to Cash Ratio | 5.7 |
| Price to Book Ratio | 1.2 |
| Dividend Yield | - |
| Shares Outstanding | 384.82M |
| Average Volume (1 week) | 7.68M |
| Average Volume (1 Month) | 10.72M |
| 52 Week Change | -45.46% |
| 52 Week High | 170.47 |
| 52 Week Low | 35.80 |
| Spread (Intraday) | 0.02 (0.05%) |
| Company Name | Moderna Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.modernatx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
